Catalyst Wire Dossier Catalyst Wire Dossier

ACULAR

Ketorolac tromethamine · Allergan, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ACULAR, covering 2012-06-14 to 2025-09-18. Get the full timeline:

Most recent: FDA Approved: ACULAR — Supplemental Application (Allergan, Inc.)

See pricing